N-arachidonoyl-dopamine
| N-arachidonoyl-dopamine | |
|---|---|
| 275px | |
| IUPAC name | (5Z,8Z,11Z,14Z)-N-[2-(3,4-dihydroxyphenyl)
ethyl]icosa-5,8,11,14-tetraenamide |
| Other names | NADA |
| Identifiers | |
| CAS number | |
| PubChem | |
| SMILES | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)
NCCC1=CC(=C(C=C1)O)O |
| Properties | |
| Molecular formula | C28H41NO3 |
| Molar mass | 439.63 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
N-arachidonoyl-dopamine, or NADA is a ligand (or chemical 'key') agonist (activator) to CB1 receptors which is an activation site for endocannabinoid and endovanilloid (aka vanilloid) ligands[1]. Specifically, NADA binds to both TRPV1 (a TRP-vanilloid cation channel receptor) and CB1 (an endocannabinoid receptor), a peculiarity among neurochemicals which normally bind to only one type of receptor.
References
- ↑ Ralevic V. (July 2003). "Cannabinoid modulation of peripheral autonomic and sensory neurotransmission.". European journal of pharmacology 472 (1-2): 1-21. PMID 12860468.
External links
- General information about NADA.
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies